The way to combat synanthropic rodents

 

(57) Abstract:

The invention relates to veterinary medicine, namely to the means for the control of rodents. The essence of the invention lies in the fact that the tool contains ethylbenzene, food-based, talc, gypsum or paraffin. When eating tools rodents on the fourth day begins their death, due to the high anticoagulant activity funds. Food base attracts rodents, which make several approaches to it, which increases its efficiency. 1 C. p. F.-ly, 4 PL.

The invention relates to veterinary medicine, namely to the means for the control of rodents.

Known tools in the fight against synanthropic rodents, for example, warfarin, cryed etc., which either belong to the group of anticoagulants, or have a high toxicity [1] the Action of these funds is based on the fact that after a single dose of these poisons from rodent or reduced blood clotting as a result of inhibition of the formation of liver prothrombin, or as a result of asphyxia respiratory tract.

However, farm animals are also very sensitive to this class of drugs, which makes use of bicheno in time, as practically effective only freshly funds, which complicates the use of these funds. In addition, there are practical difficulties in the manufacture of the tools mentioned, there is almost no re-eating rodent funds, which leads to the lack of effectiveness of the above funds.

The closest to the invention is a means to combat synanthropic rodents containing a mixture of ethylbenzene and food basics with bone meal [2] This tool has a high anticoagulant activity with the cumulative effect, however, this means also not effective enough and after a few hours lures tool collect and means is changed to a more fresh, resulting in significant labor costs.

The purpose of this invention is to improve the effectiveness of the fight against synanthropic rodents by increasing the efficiency of the eating tools that simplify the use of the tool and extending his fitness after fabrication.

This goal is achieved by the fact that it is provided with a filler of talc and gypsum or paraffin, and food base consists of bone or masochist now, wt. The coagulant ethylbenzene 0,01 0,02 Food base 60 75 vegetable Oil 2 4 Talc 12 15 Plaster or wax 8 15

Searches conducted by the patent and scientific literature showed that the proposed combination is unknown, i.e., proposed meets the criterion of "novelty."

Since all components of the means known separately, the proposed meets the criterion of "industrial applicability".

As a result of the application of this tool would result in a new effect, reflected in higher consumption means more than the simple application of the tools in practice and high security funds, the proposed meets the criterion of "inventive step".

The tool is manufactured in two modifications in the form of tablets and waxed briquettes. Tablets are used to kill rats and mice in any dry areas, they are readily eaten by rodents at any season, they can be decomposed into attics, residential and commercial additions, i.e. in the places most likely appearance of mice and rats. One tablet is almost enough to kill the rat or 4 mice. Mechanically damaged tablets do not lose their attractively menaut means in the form of waxed briquettes, which can be equally effective in winter for pickup in garden houses. The retention means in this case up to 8 months.

Medicine tablets or briquettes in rodents causes a coagulation failure and death within 4 to 14 days. Such term does not allow you to be alert to the bait, animals do not show aggression, do not refuse eating means, as is the case when using known tools mentioned. The tool does not inhalation effect when working with him and in manufacturing. The tool is a uniform brownish-gray mass with a faint odor of vegetable oil. The current tool is ethylbenzene25H20ABOUT3that is an anticoagulant indandionovogo number.

The tool was prepared as follows.

Well fragmented components of the food base and filler to form tablets with a diameter of 25 mm and a weight of about 2, Then enter ethylbenzene in 0,015, the Concentration of ethylbenzene was determined experimentally that the lower bound is due to expire on rodent (no more than 14 days), the upper the level at which the rodent is still otnoshenii, gives attractiveness to rodents that live in places with very different nutritional base. Talc in the amount of 13.5 g) was mixed with the other components provides a uniform composition. The introduction of crushed grain provides high palatability means, vegetable oil is used for flavoring appeal, an odor attractant and solvent ethylbenzene. Plaster or wax is added in the amount of 11.5 g in the composition. Mass ratio in the composition of the funds food basics (60 of 75) oil (2 4), talc (12 15) and plaster or wax (8 of 15) determined experimentally, going beyond these limits is impractical.

The tool is used as follows.

Tablets or briquettes are removed from the packaging and lay it on 3 or 6 bottles in the room where seen signs of rodents. Tablets are laid on a substrate made of paper, cardboard. Studies of eating and damaging the tablets showed that these parameters do not match. Lowest palatability noted in variants with a large amount of mineral additives and filler, although damaged, they sometimes 100% was of Great importance density tablets, highly compressed tablet version 10 was considerable damage is obovate pills, containing meal, were the most attractive. Even the scattering of these tablets were completely eaten by rats, i.e. as bait can be used and non-compacted mass. As for mice, the experiments were conducted in house and field mice showed lower compared with rats eating and damage pills. Only variants containing sunflower meal, have shown positive results.

Studies have shown that rat one eats 1 1.2 g of food, then it goes back, makes a break and comes back to food, only a hungry rat eats more bait. On this basis, the aim was to achieve a concentration ethylbenzene to 2 3 receptions money was enough to kill the rats. This corresponded to 0,015% concentration (option 15 tables). Experimental data are given in table. 1 4.

It should be noted that this tool contains waste from the food industry, i.e. cheap, highly effective and low hazard to humans and domestic animals, has a high degree of readiness for use in various conditions, especially high humidity, and long term storage.

1. The way TO COMBAT this is a SYNANTHROPIC Grisons or paraffin in the following ratio of components, wt.

Ethylbenzene 0,01 0,02

Talc 12 15

Plaster or wax 8 15

Food is the basis of the Rest

2. Means under item 1, characterized in that as a food basics use bone or meat and bone meal, meal oilseeds, grain crushed, taken in equal proportions.

 

Same patents:

The invention relates to medicine, namely neurology and physiotherapy, and can be used in the treatment of patients with neurological diseases who were exposed to small doses of ionizing radiation

The invention relates to veterinary

FIELD: medicine, pharmacy.

SUBSTANCE: invention describes sterile anesthetic composition for parenteral administration of propofol emulsified in water for injection. The composition comprise above 3 wt.-% but 6 wt.-% of less of solvent not mixing with water. Propofol is dissolved in indicated solvent. The composition is stabilized with 0.2-1.0 wt.-% of surface-active substance and has pH value level in the range 5.0-7.5. The composition with reduced pH value level allows preventing above 10-fold elevating growth of microorganisms for at least 24 h after random external pollution. Reduced fat content in composition also provides the stable analgetic effect for prolonged time and with reduced risk for the blood fat content exceeding.

EFFECT: improved and valuable properties of composition.

15 cl, 4 dwg, 4 tbl, 3 ex

FIELD: medicine, pharmaceutical industry.

SUBSTANCE: invention relates to agents used for treatment of chronic hepatitis. The hepatoprotective agent representing extract prepared from biomass of Maackia amurensis Rupr. et Maxim and obtained by the callus culture method comprises polyphenolic complex consisting of daidzein, retusin, genistein, formononetin, maackianin and medicarpin. The hepatoprotective agent promotes to effective treatment of chronic hepatitis.

EFFECT: valuable medicinal properties of agent.

2 tbl

FIELD: medicine, pharmaceutical industry, pharmacy.

SUBSTANCE: invention relates to compositions used for treatment and/or prophylaxis of chlamydium infections caused by C. pheumoniae. Pharmaceutical composition used for treatment and/or prophylaxis of chlamydium infection caused by C. pneumoniae comprises the taken phenolic compound, or extract, or fraction, or incomplete fraction comprising the taken phenolic compound or corresponding synthetic compound, or mixture of indicated compounds obtained from plants. An anti-chlamydium effect of phenolic compound or extract, or fraction, or incomplete fraction obtained from plants and comprising indicated compound or corresponding synthetic compound on C. pneumoniae represents the definite percent of inhibition for formation of inclusions. The composition useful for health eliciting an anti-chlamydium effect with respect to C. pneumoniae comprises the taken phenolic compound or extract, or fraction, or incomplete fraction containing indicated compound or corresponding synthetic compound, or mixture of indicated compounds obtained from plants. An anti-chlamydium effect of phenolic compound or extract, or fraction, or incomplete fraction comprising indicated compound or corresponding synthetic compound obtained from plants on C. pneumoniae represents the definite percent for inhibition in formation of inclusions. Also, invention relates to applying the composition useful for health in preparing foodstuffs or as supplements for nutrition for every day. Also, invention relates to applying phenolic compound or extract, or fraction, or incomplete fraction comprising indicated compound or corresponding synthetic compound or mixture of indicated compounds obtained from plants in manufacturing a medicinal agent used for treatment and/or prophylaxis of chlamydium infections caused by C. pneumoniae. An anti-chlamydium effect of phenolic compound or extract, or fraction, or incomplete fraction comprising indicated compound or corresponding synthetic compound obtained from plants on C. pneumoniae represents the definite percent in inhibition in formation of inclusions. Compositions promote to effective prophylaxis and treatment of chlamydium infections caused by C. pneumoniae.

EFFECT: valuable medicinal properties of compounds.

21 cl, 1 dwg, 1 tbl, 6 ex

FIELD: medicine, dermatology, pharmacy.

SUBSTANCE: invention relates to an antifungal preparation for external applying. The preparation comprises 2-chloro-4-nitrophenol, polyethylene glycol (PEG-400) and 50% ethyl alcohol. The preparation is used for treatment of epidermophytosis, trichophytosis, fungal eczema, cutaneous candidiasis and other diseases. Invention provides preparing the more effective antifungal preparation based on the domestic raw.

EFFECT: enhanced effectiveness of preparation, valuable medicinal properties.

2 ex

FIELD: medicine.

SUBSTANCE: means has dibunol, 15% oil extraction of propolis, gelatin, glycerol and treated water taken in known component proportion.

EFFECT: enhanced effectiveness of treatment; prolonged regenerating and antibacterial action.

2 cl

FIELD: medicine.

SUBSTANCE: means is manufactured as capsule containing dibunol and 15% oil extraction of propolis.

EFFECT: enhanced effectiveness of treatment; prolonged regenerating and antibacterial action.

2 cl

FIELD: medicine.

SUBSTANCE: method involves determining vegetative nervous system tonus in preoperative period using Kerdo index and selecting intravenous anesthetic depending its value. Parasympathetic vegetative nervous system tonus being predominant, ketamine is introduced to patient at a dose of 1-1.5 mg/kg/h during the operation. Marked sympathetic vegetative nervous system tonus being predominant, propophol is administered at a dose of 2-4 mg/kg/h. Balanced vegetative nervous system divisions tonus being observed (eutonia), both ketamine and propophol are permitted for being used in generally applied doses.

EFFECT: enhanced effectiveness of treatment; avoided undesirable hemodynamic carbodioxyperitoneum effects.

3 dwg

FIELD: medicine.

SUBSTANCE: the present innovation deals with describing propofol solubilized in aqueous micellar preparations of poloxamers being stable in low concentration. The innovation proves that these preparations are being efficient forms of propofol introduction. Propofol formulas are easily prepared being non expensive and stable, moreover, they are easily sterilized.

EFFECT: higher efficiency.

14 cl, 4 dwg, 7 ex, 5 tbl

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to the propofol anesthetic composition suitable for parenteral administration. The composition comprises propofol in the concentration from 1 mg/ml to 20 mg/ml, d-alpha-tocopheryl polyethylene glycol-1000 succinate (TPGS) in the concentration from 10 mg/ml to 200 mg/ml, and water. The mass ratio of propofol to TPGS is at least 1:10. The composition is sterilized by final sterilization in autoclave. The present composition overcomes shortcomings of the ready preparative formulation in the emulsion form, namely, it provides the stable clear product in storage under regulated temperature conditions, i. e . in cooling.

EFFECT: improved and valuable pharmaceutical properties of composition.

11 cl, 7 ex

FIELD: veterinary science.

SUBSTANCE: method involves administration of ethidium bromide in the single dose 0.5-1.0 mg/kg of mass by intramuscular route. Invention promotes to effective treatment of horses with pyroplasmosis in combination with reducing toxic effect of ethidium bromide on the horse body. Invention can be used in treatment of horses with pyroplasmosis.

EFFECT: enhanced effectiveness of treatment.

1 tbl, 2 ex

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to a pharmaceutical composition as a capsule for oral administration that comprises testosterone undecanoate as an active component dissolved in pharmaceutically acceptable liquid carrier wherein liquid carrier involves at least 50 wt.-% of castor oil. Using castor oil as a liquid carrier in combination with testosterone undecanoate as androgen provides preparing a solution that can contain about 200-250 mg of testosterone undecanoate/ml that represents the new achievement for testosterone solution for oral administration. Solution can contain lipophilic surface-active substance, such as lauryl glycol also. The composition shows good absorption in human body and elicits higher activity as compared with the known composition of undecanoate.

EFFECT: improved and valuable properties of composition.

7 cl, 1 ex

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to curative ointments with anti-inflammatory effect and with biostimulating properties for treatment of burns, suppurative and infected wounds of different etiology and to a method for treatment above said diseases using the ointment said. The proposed ointment comprising bee wax and greasy basis comprises colophony additionally. As greasy basis the ointment comprises butter and vegetable oil in the following ratio of components, wt.-%: bee wax, 20-30; butter, 30-40; vegetable oil, 15-25; colophony, 15-25. Method involves applying ointment by thin layer 0.5-3 mm on dense cotton fabric, its applying to damaged site, keeping and removing ointment with change of bandage 1-3 times per 24 h for 3-14 days. Method provides enhancing the therapeutic effectiveness of ointment due to significant acceleration the healing process of suppurative wounds and insidious furuncles being the ointment doesn't cause irritating effect.

EFFECT: improved and valuable medicinal properties of ointment.

2 cl, 4 ex

FIELD: pharmaceutical chemistry.

SUBSTANCE: pharmaceutical composition comprises efficient amount of lipophilic medicament in combination with pharmaceutical carrier. The latter consists of propylene glycol esters of C6-C18-fatty acid with 90 wt % monoester and nonionic surfactant, whose hydrophilic/lipophilic balance exceeds 10 and is suitable to solubilize lipophilic medicament. Above-mentioned surfactant is present in amount high enough to form microemulsion with ester and medicament when in contact with aqueous medium. Preferably medicament is cyclosporine.

EFFECT: increased stability of composition to provide desired pharmacokinetics and biological accessibility of lipophilic drugs essentially non soluble in water.

34 cl, 10 ex

FIELD: medicine, pharmacy.

SUBSTANCE: pharmaceutical composition possesses an anti-estrogenic effect. The composition comprises fulvestrant in ricinoleate vehicle, a pharmaceutically acceptable anhydrous ester solvent and pharmaceutically acceptable alcohol. The composition is adopted for intramuscular administration and maintains the therapeutically significant blood plasma fulvestrant concentration for at least 2 weeks. The composition for intramuscular injection provides satisfied releasing fulvestrant for prolonged time.

EFFECT: valuable medicinal and pharmaceutical properties of composition.

32 cl, 4 tbl, 1 ex

FIELD: pharmacy.

SUBSTANCE: invention relates to a granulated pharmaceutical composition comprising granulated material and erythritol. Granulated material comprises a medicinal substance of unpleasant taste and wax. Also, invention relates to a pharmaceutical product for oral using that comprises the indicated granulated composition. The composition masks unpleasant taste of a medicinal agent and provides good feeling in oral using. The granulated composition can be swallowed easily by elderly humans, children and patients suffering with dysphagia. Except for, the product is useful for administration by using a tube.

EFFECT: improved and valuable properties of composition.

15 cl, 5 tbl, 6 ex

FIELD: pharmaceutical industry.

SUBSTANCE: invention relates to parantheral composition based on oil-covered amphothericin B in form of structured emulsion containing a) oil phase (up to 30 mass/vol %), selected from vegetable oil group such as soy oil, sesame oil, safflower oil; b) amphothericin B (0.05-1 mass/vol %), dispersed in oil phase; c) water of aqueous phase; d) modified agent such as glycerol, mannitol, dextrose, dissolved in aqueous phase; and e) emulsifier, such as natural phosphatides (up to 3 mass/vol %) dispersed in aqueous phase. Composition of present invention allows achievement LD50 not less than 400 mg/kg in one dose administration and not less than 40 mg/kg in repeated administration in mice. Method for production of said composition also is disclosed.

EFFECT: parantheral composition of improved effectiveness.

14 cl, 11 ex, 15 dwg, 20 tbl

FIELD: medicine.

SUBSTANCE: the suggested peroral preparation of controlled release contains 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole as an active ingredient. T is applied for treating pollakiuria and incontinence of urine. Application of the suggested preparation provides better quality of life in a patient who should follow certain schedule and scheme of therapy without any excessive increase in the level of medicinal preparation in blood plasma due to controlling the rate for preparation's release in vivo and, also, due to decreased frequency in the intake of the suggested medicinal preparation.

EFFECT: higher efficiency of therapy.

16 cl, 4 dwg, 10 ex

Up!